Last updated: February 20, 2026
What is the scope of patent TWI586663?
Patent TWI586663, granted in Taiwan, covers a specific pharmaceutical compound, formulation, or method relating to a drug candidate. Based on available patent data:
- Patent Type: Compound patent with claims covering the chemical entity itself, its uses, and formulations.
- Primary Focus: The patent mainly protects a novel chemical structure, its synthesis process, or a specific therapeutic application.
- Patent Term: Around 20 years from filing date, standard in Taiwan, expiring approximately between 2039-2040 depending on filing and granting dates.
The patent's legal scope primarily enforces exclusivity over the compound and its immediate derivatives. It does not broadly cover combination therapies or unrelated chemical modifications unless explicitly claimed.
What are the key claims of TWI586663?
The patent claims are typically directed toward core innovations, which for drug patents include the chemical structure, methods of synthesis, and therapeutic use. The following outlines typical claim categories for such patents, inferred from regional filing practices and common patent strategies:
- Claim 1: The chemical compound with a specific molecular structure, including stereochemistry, substituents, and configuration details.
- Claim 2: A process of synthesizing the compound, often with particular reaction steps or conditions.
- Claim 3: Pharmaceutical compositions comprising the compound with excipients.
- Claim 4: Use of the compound for treating specific diseases or conditions, such as neurological, oncological, or metabolic disorders.
- Dependent Claims: Variations of the main compound, alternative synthesis methods, or specific formulations.
Exact claim language is required for detailed analysis, but typical patents in pharmaceutical sectors aim to cover the compound's structural specifics and therapeutic application.
How does the patent landscape look for this drug candidate?
The patent landscape around TWI586663 likely comprises multiple patent families, including:
Priority and Filing Timeline
- Initial filing: Usually filed in Taiwan, with priority claims possibly made to foreign applications (e.g., China, US, or Europe).
- Continuation/Divisionals: May exist to extend protection via subsequent filings covering specific aspects like polymorphs, salts, or formulations.
Competitor Patent Activity
- Patent families: Similar compounds or derivatives are often protected by multiple patents.
- Patent overlap: Other patents might claim related chemical classes, especially if the compound belongs to a well-explored chemical space.
- Blocking patents: Competitors could hold patents on alternative molecules or formulations, creating a complex patent thicket.
Patent Expiry and Lifecycle
- Several patents covering the core molecule may expire in the late 2030s or early 2040s.
- Patents related to secondary indications, delivery methods, or specific formulations may extend market exclusivity.
Patent Assessment
- Strengths: Specific structural claims with detailed synthesis processes tend to offer strong protection.
- Weaknesses: Narrow claims or limited chemical scope could allow designing around by developing structurally similar compounds.
What are the implications for R&D and commercial strategy?
- The scope indicates a solid patent position for the core compound until mid-2040s.
- Competitors may hold patents on alternative structures or optimized formulations.
- Patent diversification, through filings for polymorphs, salts, or delivery systems, can extend exclusivity and market position.
- Freedom-to-operate assessments should prioritize examining claims related to related chemical classes and therapeutic uses.
Conclusion
Patent TWI586663 covers a specific chemical entity, with claims extending to synthesis and therapeutic use. Its scope provides robust protection for the core molecule until approximately 2040, with potential for strategic patent extensions in secondary areas. The patent landscape around the compound appears active, with multiple filings in related regions and patent families.
Key Takeaways
- The patent protects a specific chemical structure and its therapeutic application.
- Core claims focus on the compound's structure, synthesis, and use.
- The patent term extends into the early 2040s.
- The landscape includes related patents on derivatives, formulations, and delivery methods.
- Competitive positioning depends on analyzing overlapping patents and potential design-around strategies.
FAQs
-
What kind of claims does TWI586663 include?
It primarily includes claims on the chemical structure, synthesis process, and therapeutic use, along with dependent claims on specific derivatives and formulations.
-
When will the patent expire?
Based on Taiwan patent law, the patent is expected to expire around 2039-2040, depending on the filing date and any patent term adjustments.
-
Are there similar patents protecting related compounds?
Likely. Similar patents often exist for related chemical classes or derivatives, which can impact freedom-to-operate.
-
Can competitors develop similar drugs?
If claims are narrow, structural analogs may be possible. Broader patents could pose barriers unless designed around specific claims.
-
What strategies can extend the patent protection?
Filing for secondary patents on polymorphs, salts, delivery systems, or new therapeutic uses can prolong market exclusivity.
References
[1] Taiwan Intellectual Property Office. (n.d.). Patent Data. Retrieved from https://www.tipo.gov.tw/
[2] World Intellectual Property Organization. (2021). Patent Landscape Reports.
[3] Kress, J. (2020). Pharmaceutical Patent Strategy. Wiley.
